{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:38:24Z","timestamp":1789663104562,"version":"4.0.1"},"reference-count":141,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1053\/j.semdp.2023.04.009","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T03:13:53Z","timestamp":1681701233000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Myeloid sarcoma: An overview"],"prefix":"10.1053","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7659-7013","authenticated-orcid":false,"given":"Maximiliano","family":"Ramia de Cap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.semdp.2023.04.009_bib0001","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2023.04.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemia: integrating morphological, clinical, and genomic data","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0003","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"issue":"14","key":"10.1053\/j.semdp.2023.04.009_bib0005","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1080\/10428194.2021.1961235","article-title":"Clinical and molecular characterization of myeloid sarcoma without medullary leukemia","volume":"62","author":"Abbas","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2023.04.009_bib0006","article-title":"Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation","author":"Nagamine","year":"2021","journal-title":"Pathology"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6357-y","article-title":"Clinical and imaging features of myeloid sarcoma: a German multicenter study","volume":"19","author":"Meyer","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0008","first-page":"265","article-title":"Granulocytic sarcoma: a systematic review","volume":"3","author":"Yilmaz","year":"2013","journal-title":"Am J Blood Res"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0009","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ejh.13056","article-title":"Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study","volume":"100","author":"Claerhout","year":"2018","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.009_bib0011","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1080\/10428194.2018.1452212","article-title":"Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates","volume":"59","author":"Hoversten","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0012","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2012.218","article-title":"Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia","volume":"26","author":"Courville","year":"2013","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.009_bib0013","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis","year":"1986","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2023.04.009_bib0014","doi-asserted-by":"crossref","unstructured":"Ramia de Cap M., Wu L.P., Hirt C., et\u00a0al. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Published online March 24, 2023:1\u20139. doi:10.1080\/10428194.2023.2185091.","DOI":"10.1080\/10428194.2023.2185091"},{"key":"10.1053\/j.semdp.2023.04.009_bib0015","doi-asserted-by":"crossref","unstructured":"el Hussein S., Hu S., Fang H., et\u00a0al. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: diagnostic challenges of an underrecognized entity. 2021;63(1):235\u2013238. doi: 10.1080\/10428194.2021.1978089.","DOI":"10.1080\/10428194.2021.1978089"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0016","doi-asserted-by":"crossref","first-page":"e05212","DOI":"10.1002\/ccr3.5212","article-title":"Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia","volume":"10","author":"Rizzuto","year":"2022","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bjh.17742","article-title":"De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases","volume":"195","author":"Begna","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0018","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/cncr.10399","article-title":"Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature","volume":"94","author":"Yamauchi","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2023.04.009_bib0019","unstructured":"Neiman R.S., Barcos M., Berard C., et\u00a0al. Granulocytic sarcoma: a clinicopathologic study of 67 biopsied cases. 2023."},{"key":"10.1053\/j.semdp.2023.04.009_bib0020","doi-asserted-by":"crossref","unstructured":"Tsimberidou A.M., Kantarjian H.M., Estey E., et\u00a0al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. 2023. doi:10.1038\/sj.leu.2402958.","DOI":"10.1038\/sj.leu.2402958"},{"issue":"Supplement_1","key":"10.1053\/j.semdp.2023.04.009_bib0021","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood-2019-123308","article-title":"Impact of Upfront Chemotherapy on overall survival in isolated myeloid sarcoma","volume":"134","author":"Lontos","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0022","first-page":"1","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0023","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/10428194.2014.963080","article-title":"Presentation and outcomes among patients with isolated myeloid sarcoma: a surveillance, epidemiology, and end results database analysis","volume":"56","author":"Movassaghian","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0024","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5045\/br.2017.52.3.184","article-title":"Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"key":"10.1053\/j.semdp.2023.04.009_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.leukres.2016.12.003","article-title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","volume":"53","author":"Lazzarotto","year":"2017","journal-title":"Leuk Res"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"10.1053\/j.semdp.2023.04.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18038","article-title":"Very late extramedullary relapse of acute myeloid leukaemia as prostatic myeloid sarcoma occurring 24 years post-allograft","author":"Taylor","year":"2022","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0028","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev"},{"key":"10.1053\/j.semdp.2023.04.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/10428194.2012.720375","article-title":"Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplantation for adult acute myelogenous leukemia","volume":"54","author":"Kogut","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0031","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.leukres.2013.08.017","article-title":"Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia","volume":"37","author":"Shimizu","year":"2013","journal-title":"Leuk Res"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0032","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2019.01.011","article-title":"Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Yuda","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0033","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2012.073189","article-title":"Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"98","author":"Harris","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-021-01141-z","article-title":"Case report: rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations","volume":"16","author":"Wu","year":"2021","journal-title":"Diagn Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0035","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41375-020-0903-0","article-title":"Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney","volume":"34","author":"Wong","year":"2020","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2023.04.009_bib0036","first-page":"1","article-title":"Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor","volume":"2015","author":"Palanisamy","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0037","doi-asserted-by":"crossref","unstructured":"Otsuji C., Girard J.;., Spier N.;., Fuchs C.;., Lai D.; Sibling donor-derived myeloid sarcoma after hematopoietic stem cell transplant Item Type Article; text Sibling donor-derived myeloid sarcoma after hematopoietic stem cell transplant. Published online 2021. doi:10.1016\/j.ehpc.2021.200512.","DOI":"10.1016\/j.ehpc.2021.200512"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0038","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5045\/kjh.2010.45.1.70","article-title":"A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation","volume":"45","author":"Jeong","year":"2010","journal-title":"Korean J Hematol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0039","first-page":"1","article-title":"Donor cell myeloid sarcoma","volume":"2014","author":"Walshauser","year":"2014","journal-title":"Case Rep Hematol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0040","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1016\/j.bbmt.2014.11.457","article-title":"Donor cell cardiac myeloid sarcoma following umbilical cord transplantation","volume":"21","author":"Hayes","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.009_bib0041","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2011.041418","article-title":"Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation","volume":"96","author":"Chevallier","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0042","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid Leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hon.994","article-title":"Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma","volume":"30","author":"Avni","year":"2012","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0044","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni","year":"2011","journal-title":"Ther Adv Hematol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.009_bib0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1200\/JOP.18.00753","article-title":"Venetoclax for refractory myeloid sarcoma","volume":"15","author":"Kanate","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1053\/j.semdp.2023.04.009_bib0046","first-page":"72","article-title":"Extramedullary acute myeloid leukemia (eAML): retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes","author":"Halahleh","year":"2021","journal-title":"Ann Med Surg"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0047","first-page":"989","article-title":"Myeloid sarcoma: a clinicopathological study with emphasis on diagnostic difficulties","volume":"13","author":"Kudva","year":"2017","journal-title":"J Cancer Res Ther"},{"issue":"29","key":"10.1053\/j.semdp.2023.04.009_bib0048","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0083-6","article-title":"RTK-RAS pathway mutation is enriched in myeloid sarcoma","volume":"8","author":"Choi","year":"2018","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-2-42","article-title":"Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study","volume":"2","author":"Alexiev","year":"2007","journal-title":"Diagn Pathol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0051","doi-asserted-by":"crossref","unstructured":"Goyal G., Bartley A.C., Patnaik M.M., Litzow M.R., Al-Kali A., Go R.S. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Nature Publishing Group. Published online 2017. doi:10.1038\/bcj.2017.79.","DOI":"10.1038\/bcj.2017.79"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0052","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.clml.2018.03.013","article-title":"Myeloid sarcoma predicts superior outcome in pediatric AML; Can cytogenetics solve the puzzle?","volume":"18","author":"Pramanik","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0053","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5114\/pjp.2018.79545","article-title":"Increased angiogenesis seems to correlate with inferior overall survival in myeloid sarcoma patients","volume":"69","author":"Piccaluga","year":"2018","journal-title":"Pol J Pathol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0054","article-title":"T315I-mutated myeloid sarcoma","volume":"12","author":"Zhang","year":"2019","journal-title":"Leuk Res Rep"},{"issue":"23","key":"10.1053\/j.semdp.2023.04.009_bib0055","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1182\/bloodadvances.2021004983","article-title":"In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported","volume":"5","author":"Anekpuritanang","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0056","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0057","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by 18 FDG-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"St\u00f6lzel","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0058","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1016\/j.clml.2020.06.009","article-title":"Prognostic impact of extramedullary infiltration in pediatric low-risk acute myeloid leukemia: a retrospective single-center Study Over 10 Years","volume":"20","author":"Hua","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0059","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/08880018.2020.1803462","article-title":"Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21)","volume":"38","author":"Hu","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.009_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/children4120113","article-title":"A rare case of pure erythroid sarcoma in a pediatric patient: case report and literature review","volume":"4","author":"Manresa","year":"2017","journal-title":"Children"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.009_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29848","article-title":"Identification of RCC1-LCK as a novel fusion gene in pediatric erythroid sarcoma","volume":"69","author":"Oya","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"NOV","key":"10.1053\/j.semdp.2023.04.009_bib0062","article-title":"Cutaneous leukemic infiltrates successfully treated with biomodulatory therapy in a rare case of Therapy-Related High Risk MDS\/AML","volume":"9","author":"Heudobler","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0063","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1163\/156855902760262826","article-title":"Extensive pulmonary infiltration by leukemic blasts successfully treated with hydroxyurea\u2013a case report","volume":"32","author":"Huang","year":"2002","journal-title":"Haematologia"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0064","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hemonc.2020.02.007","article-title":"The first case of acute myeloid leukaemia\/myeloid sarcoma with cytokeratin expression on blasts diagnosed on urine specimen","volume":"14","author":"Comerford","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPO58YWIBUBESX","article-title":"Extramedullary manifestations of myeloid neoplasms","volume":"144","author":"Wilson","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.009_bib0066","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas [5]","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.009_bib0067","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PAI.0000000000000783","article-title":"Myeloid sarcoma of the testis in children: clinicopathologic and immunohistochemical characteristics with KMT2A (MLL) gene rearrangement correlation","volume":"28","author":"el Jamal","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.009_bib0068","first-page":"790","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0069","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2001-125-1448-CKCRIE","article-title":"c-Kit (CD117) reactivity in extramedullary myeloid tumor\/granulocytic sarcoma","volume":"125","author":"Chen","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/labmed\/lmab025","article-title":"Myeloid sarcoma expressing keratins and mimicking carcinoma-case report and literature review","volume":"53","author":"Dayton","year":"2022","journal-title":"Lab Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0071","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0072","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2023.04.009_bib0073","doi-asserted-by":"crossref","unstructured":"Schnittger S., Schoch C., Kern W., et\u00a0al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Published online 2005. doi:10.1182\/blood-2005-06-2248.","DOI":"10.1182\/blood-2005-06-2248"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.009_bib0074","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2010-01-266908","article-title":"A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias","volume":"116","author":"Gruszka","year":"2010","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.semdp.2023.04.009_bib0075","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/blood-2018-01-828467","article-title":"High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML","volume":"131","author":"Patel","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0076","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/106689690301100404","article-title":"Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis","volume":"11","author":"Audouin","year":"2003","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.009_bib0077","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.semdp.2020.06.002","article-title":"Myeloid diseases in the lung and pleura","volume":"37","author":"Khoury","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"1\u20132","key":"10.1053\/j.semdp.2023.04.009_bib0078","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002770050417","article-title":"Extramedullary granulopoiesis mimicking recurrent lymphoma after prolonged administration of human recombinant granulocyte colony-stimulating factor","volume":"77","author":"Friedman","year":"1998","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0079","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1537-2995.2001.41020184.x","article-title":"Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs","volume":"41","author":"Platzbecker","year":"2001","journal-title":"Transfusion"},{"issue":"16","key":"10.1053\/j.semdp.2023.04.009_bib0080","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1182\/blood-2018-09-875047","article-title":"Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations","volume":"133","author":"Jutzi","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0081","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2017-07-793620","article-title":"Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow","volume":"131","author":"Lazarevic","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0082","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bjh.12742","article-title":"Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy","volume":"165","author":"Srinivas","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0083","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-015-0026-x","article-title":"Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing","volume":"4","author":"Mandelker","year":"2015","journal-title":"Exp Hematol Oncol"},{"issue":"21","key":"10.1053\/j.semdp.2023.04.009_bib0084","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1182\/blood.V122.21.5033.5033","article-title":"Extramedullary myeloid sarcoma with eosinophilia and FIP1L1-Pdgfra rearrangement: complete cytogenetic response to Imatinib therapy","volume":"122","author":"Matrai","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/PAS.0b013e31826df00b","article-title":"A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease","volume":"37","author":"Chen","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0086","doi-asserted-by":"crossref","DOI":"10.1186\/1756-8722-7-26","article-title":"Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia","volume":"7","author":"Shah","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0087","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival","volume":"22","author":"Werstein","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1053\/j.semdp.2023.04.009_bib0088","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.humpath.2020.11.005","article-title":"Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia","volume":"108","author":"Greenland","year":"2021","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0089","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-020-04313-x","article-title":"Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow","volume":"100","author":"Engel","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semcancer.2019.07.025","article-title":"Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms","volume":"60","author":"Valent","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"25","key":"10.1053\/j.semdp.2023.04.009_bib0091","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2023.04.009_bib0092","article-title":"Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia","volume":"17","author":"Ebian","year":"2022","journal-title":"Leuk Res Rep"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0093","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.leu.2403626","article-title":"BCR\/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR\/ABL-positive cells","volume":"19","author":"Jongen-Lavrencic","year":"2005","journal-title":"Leukemia"},{"issue":"3\u20134","key":"10.1053\/j.semdp.2023.04.009_bib0094","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10428199209067601","article-title":"All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia","volume":"21","author":"di Noto","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0095","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1038\/oncsis.2015.6","article-title":"RUNX1\/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1","volume":"4","author":"Ponnusamy","year":"2015","journal-title":"Oncogenesis"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0096","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.5858\/arpa.2012-0537-OA","article-title":"Myeloid sarcoma of the head and neck region","volume":"137","author":"Zhou","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0097","first-page":"333","article-title":"Myeloid sarcoma with CBFB-MYH11 Fusion (inv(16) or t(16;16)) prevails in the abdomen","volume":"153","author":"Dalland","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0098","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.3324\/haematol.2015.129346","article-title":"NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features","volume":"100","author":"Luskin","year":"2015","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0099","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/ajh.25594","article-title":"Extramedullary leukemia behaving as solid cancer: clinical, histologic, and genetic clues to chemoresistance in organ sites","volume":"94","author":"Cunningham","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-020-00200-9","article-title":"Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia","volume":"8","author":"Kunadt","year":"2020","journal-title":"Biomark Res"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0102","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","article-title":"Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing","volume":"59","author":"Kashofer","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2023.04.009_bib0103","doi-asserted-by":"crossref","unstructured":"Pastoret C., Houot R., Llamas-Gutierrez F., et\u00a0al. Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing. 2016;58(4):1008\u20131012. doi:10.1080\/10428194.2016.1225208.","DOI":"10.1080\/10428194.2016.1225208"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.009_bib0104","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/s41375-018-0056-6","article-title":"Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1\/2 mutations","volume":"32","author":"Willekens","year":"2018","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2023.04.009_bib0105","article-title":"Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy","author":"Shallis","year":"2021","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0106","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1309\/WWW7-DG6X-HC16-D7J2","article-title":"Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow","volume":"114","author":"Chang","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"7728","key":"10.1053\/j.semdp.2023.04.009_bib0107","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0108","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.ymthe.2018.08.001","article-title":"A novel anti-LILRB4 CAR-T cell for the treatment of monocytic AML","volume":"26","author":"John","year":"2018","journal-title":"Mol Ther"},{"key":"10.1053\/j.semdp.2023.04.009_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100802","article-title":"Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL\/AF10 with activating KRAS mutation in a mouse transplantation model: hoxa11 in myeloid sarcoma formation","volume":"29","author":"Fu","year":"2022","journal-title":"Neoplasia"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0111","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005792-197605000-00005","article-title":"Causes of death in adults with acute leukemia","volume":"55","author":"Chang","year":"1976","journal-title":"Medicine"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0112","doi-asserted-by":"crossref","first-page":"e28099","DOI":"10.1002\/pbc.28099","article-title":"Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: recent experiences of the Dutch Childhood Oncology Group","volume":"67","author":"Klein","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0113","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaoncol.2016.4858","article-title":"Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit","volume":"3","author":"Halpern","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0114","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00432-020-03128-7","article-title":"Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia","volume":"146","author":"Xu","year":"2020","journal-title":"JCancer Res Clin Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0115","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000001623","article-title":"Prognostic role of postinduction minimal residual disease and myeloid sarcoma type extramedullary involvement in pediatric RUNX1-RUNX1T1 (+) acute myeloid leukemia","volume":"42","author":"Lee","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijrobp.2018.05.045","article-title":"Use of radiation in extramedullary leukemia\/chloroma: guidelines from the international lymphoma radiation oncology group","volume":"102","author":"Bakst","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semdp.2023.04.009_bib0118","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.671514","article-title":"Radiation therapy for chemotherapy refractory gingival myeloid sarcoma","volume":"11","author":"Lee","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0119","first-page":"216","article-title":"Clinical outcome of allogeneic hematopoietic stem cell transplantation in the treatment of 9 myeloid leukemia patients with granulocytic sarcoma","volume":"57","author":"Liang","year":"2018","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000518356","article-title":"A relapsing meningeal acute myeloid leukaemia FLT3-ITD+ responding to gilteritinib","volume":"66","author":"Perrone","year":"2021","journal-title":"Chemotherapy"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.009_bib0121","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3390\/cancers14092186","article-title":"Target therapy for extramedullary relapse of FLT3-ITD acute myeloid leukemia: emerging data from the field","volume":"14","author":"Duminuco","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0122","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000524878","article-title":"Gilteritinib in isolated breast relapse of FLT3 positive acute myeloid leukemia: a case report and review of literature","volume":"145","author":"Arrigo","year":"2022","journal-title":"Acta Haematol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0123","article-title":"Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Iannotta","year":"2022","journal-title":"Leuk Res Rep"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0124","first-page":"1469","article-title":"Cost-effectiveness of gilteritinib for relapsed\/refractory FLT3mut+ acute myeloid leukemia","volume":"27","author":"Pandya","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.009_bib0125","doi-asserted-by":"crossref","first-page":"E174","DOI":"10.1097\/MPH.0000000000001201","article-title":"Clinical and radiographic response of extramedullary leukemia in patients treated with gemtuzumab ozogamicin","volume":"41","author":"McNeil","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.semdp.2023.04.009_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106583","article-title":"Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen","volume":"106","author":"Ibrahim","year":"2021","journal-title":"Leuk Res"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.009_bib0127","article-title":"Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia","volume":"14","author":"Ovilla-Martinez","year":"2021","journal-title":"BMJ Case Rep CP"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-021-01328-y","article-title":"The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report","volume":"21","author":"Shatilova","year":"2021","journal-title":"BMC Womens Health"},{"key":"10.1053\/j.semdp.2023.04.009_bib0129","first-page":"1","article-title":"Successful treatment of myeloid sarcoma in an elderly patient with myelodysplastic syndrome with reduced-dose azacitidine","volume":"2021","author":"Sato","year":"2021","journal-title":"Case Rep Hematol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.009_bib0130","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00277-018-3314-9","article-title":"Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report","volume":"97","author":"Castelli","year":"2018","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPH.0000000000001383","article-title":"Successful treatment of relapsed pediatric acute myeloid leukemia presenting as central nervous system myeloid sarcoma: a single-institution case series","volume":"42","author":"Bujold","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0132","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.009_bib0133","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000517389","article-title":"Myeloid sarcoma: diagnostic and treatment tools from a monocentric retrospective experience","volume":"145","author":"Bianchi","year":"2022","journal-title":"Acta Haematol"},{"issue":"13","key":"10.1053\/j.semdp.2023.04.009_bib0134","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.009_bib0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12185-021-03081-2","article-title":"Characteristics and transplant outcome of myeloid sarcoma: a single-institute study","volume":"113","author":"Shan","year":"2021","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.009_bib0136","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bjc.6601120","article-title":"Survival analysis Part III: multivariate data analysis - Choosing a model and assessing its adequacy and fit","volume":"89","author":"Bradburn","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semdp.2023.04.009_bib0137","article-title":"Limitations of multivariate survival analysis","author":"Ramia de Cap","year":"2021","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.009_bib0138","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcab022","article-title":"Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer","volume":"3","author":"Wiegmans","year":"2021","journal-title":"NAR Cancer"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.009_bib0139","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0140","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.009_bib0141","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group","volume":"25","author":"Dusenbery","year":"2003","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:23:48Z","timestamp":1760037828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257023000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":141,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0740257023000382"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.04.009","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid sarcoma: An overview","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}